Eli Lilly's Cialis is rapidly winning market share from Viagra, Pfizer's trailblazing erectile dysfunction (ED) drug, which is now starting …
For the second time in three years, the National Health Service has undergone an April revolution through the major re-engineering …
AstraZeneca's Crestor has suffered a setback in the US as its share in the highly competitive statin market fell back …
A new survey of GPs shows they find medical publications to be the most useful of all media – results …
The long-awaited new General Medical Services contract has arrived, with the majority of general practices in the UK now working …
'Inspecting, informing, improving' is the motto of the new watchdog for both the NHS and private healthcare facilities.
When looking at the performance of new products there are many reasons for their possible success. Perhaps GPs hooked into …
US biotech Amgen is to buy gene regulation specialist Tularik in a move that will add five drug candidates to …
Aid agencies are claiming that plans to provide antiretroviral treatment for millions of people with HIV are being undermined by …
Pharmaceutical company sales teams have grown significantly in size over the last few years the – figures vary, but by …
New warnings about the prescribing of the Selective Serotonin Reuptake Inhibitor (SSRI) class of antidepressants have been issued in the …
German pharmaceutical company Bayer has posted the biggest losses in its history after paying a hefty price for restructuring the …
Altana Pharma and Solvay Healthcare are to launch a novel 'time-swap' co-promotional agreement to make the most of their salesforces' …